Search hospitals > Arizona > Scottsdale
HonorHealth Research Institute
Claim this profileScottsdale, Arizona 85258
Global Leader in Solid Tumors
Global Leader in Tumors
Conducts research for Pancreatic Cancer
Conducts research for Cancer
Conducts research for Melanoma
152 reported clinical trials
14 medical researchers
Summary
HonorHealth Research Institute is a medical facility located in Scottsdale, Arizona. This center is recognized for care of Solid Tumors, Tumors, Pancreatic Cancer, Cancer, Melanoma and other specialties. HonorHealth Research Institute is involved with conducting 152 clinical trials across 191 conditions. There are 14 research doctors associated with this hospital, such as Michael S Gordon, MD, Vincent Chung, MD, Erkut Borazanci, MD, and Sunil Sharma.Area of expertise
1Solid Tumors
Global LeaderStage IV
Stage III
metastatic
2Tumors
Global LeaderStage IV
Stage III
metastatic
Top PIs
Michael S Gordon, MDHonor Health Research Institute1 year of reported clinical research
Studies Tumors
Studies Solid Tumors
17 reported clinical trials
25 drugs studied
Vincent Chung, MDCity of Hope Medical Center1 year of reported clinical research
Expert in Adenocarcinoma
Expert in Pancreatic Cancer
19 reported clinical trials
31 drugs studied
Erkut Borazanci, MDHonorHealth1 year of reported clinical research
Studies Pancreatic Cancer
Studies Solid Tumors
13 reported clinical trials
22 drugs studied
Sunil SharmaHonorHealth Research Institute4 years of reported clinical research
Studies Tumors
Studies Cancer
16 reported clinical trials
34 drugs studied
Clinical Trials running at HonorHealth Research Institute
Solid Tumors
Melanoma
Tumors
Non-Small Cell Lung Cancer
Cancer
Colorectal Cancer
Ovarian Cancer
Breast Cancer
Stomach Cancer
Endometrial Cancer
Dabrafenib + Trametinib Access
for Cancer
This study is to provide access for patients who are receiving treatment with dabrafenib and/or trametinib in a Novartis-sponsored Oncology Global Development, Global Medical Affairs or a former GSK-sponsored study who have fulfilled the requirements for the primary objective, and who are judged by the investigator as benefiting from continued treatment in the parent study as judged by the Investigator at the completion of the parent study.
Recruiting3 awards Phase 42 criteria
INBRX-109
for Solid Tumors
This trial tests INBRX-109, a protein that attaches to harmful cells and signals the body to destroy them. It targets patients with conditions involving DR5, like certain cancers.
Recruiting1 award Phase 1
GIM-531
for Solid Tumors
GIM-531 is a first-in-class, orally bioavailable small molecule that is being developed for the treatment of advanced solid tumors as a single agent and rescue therapy. GIM-531 exhibits its primary effect through selective inhibition of regulatory T-cells (Tregs).
Recruiting1 award Phase 1 & 24 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at HonorHealth Research Institute?
HonorHealth Research Institute is a medical facility located in Scottsdale, Arizona. This center is recognized for care of Solid Tumors, Tumors, Pancreatic Cancer, Cancer, Melanoma and other specialties. HonorHealth Research Institute is involved with conducting 152 clinical trials across 191 conditions. There are 14 research doctors associated with this hospital, such as Michael S Gordon, MD, Vincent Chung, MD, Erkut Borazanci, MD, and Sunil Sharma.